Get started
BIONTECH SEBIONTECH SEBIONTECH SE

BIONTECH SE

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

22UA trade ideas

BNTX (BioNTech) - Bullish end to quarterBioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany. Analysis/Commentary Strong EPS and Sales Growth Y-on-Y Based on the study of the previous quarterly earnings reports and subsequent price moves: - Current quarter has given stronf price move above anticipated LOW point - Still plenty more room for a move to MID point and beyond before quarter end - Trailing stop-loss on price above MID point GOOD LUCK. DO YOUR OWN RESEARCH!
NASDAQ:BNTXLong
by kennzo
Symmetrical Triangle? A symmetrical triangle can break either way, up or down. A break of 94.80 could signal a move down. Not a recommendation. If price stops at the .786, this could be a gartley pattern which would be bullish. If it drops below the .786, will be a farther drop of course. I am not gonna hold my breath though. (o: Looks a bit too risky to go long on this one right now. A symmetrical triangle needs 5 touches to be valid. 2 touches to one trndline and 3 to the other. sometimes the 5th touch can determine direction but price can hang inside for a while without breaking up or down. It is a consolidation pattern and direction to be determined. The top trendline is resistance and the bottom is support until price (the market) decides which way this to go.
NASDAQ:BNTX
by lauralea
$BNTX PT 300 and higher$PFE and $BNTX Partnership Pfizer Is Ready, Even For COVID-19 Variants This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), and Bristol-Myers Squibb Co (NYSE: BMY) reporting earnings. But, what is under the spotlight is the effort pharmaceutical and biotech companies are making to combat COVID-19 or more precisely, the vaccine. Pfizer was the first who brought it to the market and gained FDA approval along with using the ground-breaking mRNA technology successfully. Pfizer's Scientific Success
NASDAQ:BNTXLong
by BADQOMOCAWGOWLD
2
Short and long term forecast for BiontechThe stocks of Biontech could be one of the best in the near few month. To eleborate this statement I have to do a quick review of the last weeks: 1) We are moving in a clear parallel channel and hit the upper border line. It was also an 1:1 extention of previous higher highs and lower lows. On a technical standpoint it was normal to see a drop. Furthermore, it was before X-Mas, were people tend to withdraw money for presents and taxes. 2) Point 2 should have been a good rebuy spot. It hit the median line of the parallel channel and we retraced to the 0.382 Fibonacci point. Exactly on that date, the news about the new UK covid mutation occured, which caused a FUD for the inexperienced traders. Therefore we droped lower than normal. 3) On that point we had strong horizontal support and hit the golden zone of the Fibonacci retracment. A perfekt buy! Now we are again at Point 2), but what changed since then? Biontech has proven that it's effective against the UK and all other mutations. Before that point, there were only estimations that Biontech would produce 1 to 1.3 billion units of the vaccine. Now we have a statement of the CEO that Biontech will produce 2 billion units! All old calculations have to be readjusted. Biontech announced the mRNA-technologie for multiple sclerosis The biggest shareholder of Biontech announced, that Biontech will become an own producing big farma company All that are bullish news which are not calculated in the current stock price. Risk reward ratio for the upcoming weeks: First of all let's see the potential target for a short term drop. A price around 73-75€ would hit a strong horizontal support, which is the golden zone retracment of the last upwards move and also the zone of the maximal traded volume (orange line). That potential -15% move would be a strong target for traders to go long with an easy stop/loss target below the parallel channel. The target for a short term upwards movement would be around 115€. That yellow arrow is an 1:1 extention of the current upwards movement. Going upwards would cause a fast move due to the last swifty drop form 109€. The target of 115€ would also hit the border of the parallel channel. We should see some resistance on that point again. The long term target is tricky to calculate. The most obvious method is to draw an Fib extention from the last big moves. We should see a target at 128€ and 168€. At first glance, that targets look slightly to high, BUT if we had an ATH of 109€ with calculated 1.3 billion units of the vaccine and if we extent that calculation with 2 billion units, we get a price of 166,77€ (109€ * 1.53) ;-) Risk reward ratio: With that trade we have a 1 to 5.5 risk to reward ratio, which every trader should be keen to it and a potential to nearly double our money.
FWB:22UALong
by MuffyPuffy
1